MedTrace Logo

A Study of Minirin Melt in 24 Months Treatment in Patients With Nocturia

NCT01552395 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4136

Last updated 2016-05-24

No results posted yet for this study

Summary

A Confirmation of the Safety Profile for Minirin Melt in Clinical Practice

Conditions

  • Nocturia

Sponsors & Collaborators

  • Ferring Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Clinical Development Support · Ferring Pharmaceuticals

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01552395 on ClinicalTrials.gov